131I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study

被引：0

作者：

Kuan-Yin Ko

Chia-Hung Kao

Cheng-Li Lin

Wen-Sheng Huang

Ruoh-Fang Yen

机构：

[1] National Taiwan University Hospital,Department of Nuclear Medicine

[2] China Medical University,Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine

[3] China Medical University Hospital,Department of Nuclear Medicine and PET Center

[4] China Medical University Hospital,Management Office for Health Data

[5] China Medical University,College of Medicine

[6] Changhua Christian Hospital,Department of Nuclear Medicine

[7] National Taiwan University Hospital,Department of Nuclear Medicine

[8] National Taiwan University College of Medicine,Department of Radiology

来源：

European Journal of Nuclear Medicine and Molecular Imaging | 2015年 / 42卷

关键词：

Radioiodine; Thyroid cancer; Salivary gland; Lacrimal gland; Second primary malignancy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1172 / 1178

页数：6